BioWorld

Sep. 27, 2004

View Archived Issues

Money Raised Year To Date

Read More

Stock Winners and Losers For The Week

Read More

Biotech Mergers And Acquisitions: May 27 - Sept. 22, 2004#

Read More

Tarceva Ushering OSI Toward Critical Juncture' In Evolution

Tarceva, the eye-opening cancer drug with a new drug application pending, typically is regarded as another feather in the cap of Genentech Inc., whose headgear already is festooned with plumage. Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More